相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases
Jakko van Ingen et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease
David C. Alexander et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria
Barbara A. Brown-Elliott et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort
Sanne Zweijpfenning et al.
RESPIRATORY MEDICINE (2017)
Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease
Bumhee Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Inhibition of the β-Lactamase BlaMab by Avibactam Improves the In Vitro and In Vivo Efficacy of Imipenem against Mycobacterium abscessus
Anne-Laure Lefebvre et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Randomized Trial of Liposomal Amikacin for Inhlation in Nontuberculous Mycobacterial Lung Disease
Kenneth N. Olivier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin
Beatriz E. Ferro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease
Beatriz E. Ferro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease
Beatriz E. Ferro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease
Devyani Deshpande et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection
Beatriz E. Ferro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Intermittent Antibiotic Therapy for Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
Byeong-Ho Jeong et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Pulmonary Nontuberculous Mycobacterial Infection A Multisystem, Multigenic Disease
Eva P. Szymanski et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models
Andres Obregon-Henao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
Richard J. Wallace et al.
CHEST (2014)
In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus
Isabelle Lerat et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence
Jakko van Ingen et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance
Aurelia M. Schmalstieg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
Won-Jung Koh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs
Jiwon Lyu et al.
RESPIRATORY MEDICINE (2011)
ATP Synthase Inhibition of Mycobacterium avium Is Not Bactericidal
Nacer Lounis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
分享论文
